Are AMS Polymers Ltd latest results good or bad?

2 hours ago
share
Share Via
AMS Polymers Ltd's latest results are concerning, showing only 1.35% sales growth and a 41.18% decline in net profit, alongside negative operating cash flows and financial instability, indicating significant operational challenges.
AMS Polymers Ltd's latest financial results for the quarter ended March 2026 reveal a complex picture of the company's operational performance. The company reported net sales of ₹28.50 crores, reflecting a modest year-on-year growth of 1.35%, which is significantly lower than the previous year's impressive growth. The net profit for the quarter was ₹0.10 crores, marking a decline of 41.18% compared to the same period last year, indicating challenges in maintaining profitability.
The operating profit margin, excluding other income, was recorded at 1.58%, which represents a slight contraction from the previous quarter. This suggests that while revenue has shown some recovery, it has not translated into improved operational efficiency or profitability. The company's PAT margin stood at 0.35%, highlighting the thin profitability that leaves little room for operational disruptions. Additionally, the financial results indicate a concerning trend in cash flow dynamics, with negative operating cash flows persisting over multiple years. The reliance on external financing to support operations raises questions about the sustainability of the business model. The company's balance sheet also shows a significant mismatch between current liabilities and shareholder funds, which could pose risks to financial stability. In terms of evaluation, AMS Polymers experienced an adjustment in its evaluation, reflecting the ongoing challenges in its operational performance and financial metrics. The volatility in profitability and the lack of institutional support further complicate the outlook for the company. Overall, the results underscore the need for AMS Polymers to address its operational inefficiencies and enhance its financial health to improve its standing in the market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News